Benefits
Fasting and post-meal blood sugar in two small trials
Two small studies in adults with type 2 diabetes measured blood sugar on curry leaf. One using 12 g of leaf powder a day for a month found only a temporary dip in fasting and post-meal readings that faded by day 30. A weaker extract-capsule study over 45 days reported lower fasting and post-meal sugar and HbA1c. The results are inconsistent, and curry leaf is not a treatment for diabetes.
Body weight and fat accumulation in animal studies
In mice and rats fed a high-fat diet, curry leaf extracts and the isolated alkaloid mahanimbine slowed weight gain and reduced fat build-up in fat tissue and the liver, and one study found more dietary fat passed out in the stool. These are animal findings at doses far above a culinary amount, and body weight has not been tested in people.
Blood cholesterol and triglycerides in laboratory and animal work
In high-fat-diet rodents, curry leaf extracts and mahanimbine lowered total cholesterol and triglycerides. The only human trial to measure blood fats, in 30 adults with type 2 diabetes taking leaf powder for a month, found no appreciable change in cholesterol, lipoprotein fractions or triglycerides. The evidence for blood fats in people is unsupportive.
Starch-digesting enzyme activity in laboratory tests
In test-tube assays, aqueous curry leaf extract slowed alpha-amylase, an enzyme that breaks starch down into glucose, in a concentration-dependent way. Slowing this enzyme is one proposed route by which a food might blunt the rise in blood sugar after a starchy meal. This is a laboratory result only and has not been confirmed in people.
Antioxidant markers in animal studies
In rats with chemically induced diabetes, an ethanol extract of curry leaf lowered malondialdehyde, a marker of fat oxidation, and raised reduced glutathione, a cellular antioxidant, alongside lower blood glucose. Laboratory antioxidant readings do not predict health effects, and these changes have not been shown in people taking curry leaf.
Mechanism of action
Carbazole alkaloids as the studied actives
Curry leaf is rich in carbazole alkaloids, including mahanimbine, koenimbine, girinimbine and mahanine. In laboratory and animal studies these compounds, mahanimbine above all, account for most of the reported effects on fat accumulation and blood sugar. The leaf also supplies fiber and aromatic volatile oils.
Slowing carbohydrate digestion (proposed)
One proposed route for a blood-sugar effect is slowing enzymes such as alpha-amylase that turn starch into glucose, which was seen in test-tube assays, together with the fiber in whole leaf powder slowing sugar absorption. Neither mechanism has been confirmed as a clinical effect in people.
Effects on fat metabolism in animals
In high-fat-diet rodents, curry leaf alkaloids reduced fat storage in adipose tissue and the liver, increased fat excretion in the stool, and improved the activity of insulin-responsive genes. These are animal mechanisms and were not measured in the human trials.
Antioxidant activity in laboratory and animal studies
Curry leaf compounds scavenge reactive oxygen species in test-tube assays, and in diabetic animals the extract lowered oxidative-stress markers and raised glutathione. How much of this reaches human tissues after an oral dose was not measured in the human trials.
Clinical trials
One-month supplementation study of 12 g/day curry leaf powder (about 2.5 g fiber) with no placebo group; fasting and 2-hour post-meal blood sugar, serum lipids, lipoprotein fractions, triglycerides and glycated proteins measured at days 1, 15 and 30. (Iyer and Mani 1990, Plant Foods Hum Nutr)
30 adults with non-insulin-dependent (type 2) diabetes in India.
Fasting and post-meal blood sugar dipped at day 15, but the reduction was transient and faded by day 30. There was no appreciable change in serum total cholesterol, lipoprotein cholesterol fractions, triglycerides, glycated serum proteins or amino acids over the month. A small, uncontrolled study with largely null results.
A 45-day study of encapsulated aqueous curry leaf extract at 5 or 10 mg/kg of body weight in two treatment groups; fasting blood sugar, random blood sugar and HbA1c were measured on day 0 and day 45. The report does not describe a placebo group and used a day-0-versus-day-45 comparison. (Farooq et al. 2023, Pak J Pharm Sci)
45 adult women with type 2 diabetes in Pakistan.
Fasting blood sugar, random blood sugar and HbA1c fell significantly from baseline in both dose groups. With no described placebo group and a within-group comparison only, the result is weak, and it appeared in a special journal issue.
A 12-week study of the curry leaf alkaloid mahanimbine at 2 or 4 mg/kg of body weight added to a high-fat diet in male and female mice. (Jagtap et al. 2017, Biofactors)
Male and female mice on a high-fat diet; not a human study.
Mahanimbine reduced high-fat-diet weight gain, hyperlipidemia and fat accumulation in adipose tissue and liver, improved glucose clearance, and increased fat excretion in the stool. An animal study at doses far above culinary intake; no human data.
A two-week study of dichloromethane and ethyl acetate curry leaf extracts at 300 mg/kg/day, and mahanimbine at 30 mg/kg/day, in high-fat-diet obese rats. (Birari et al. 2010, Fitoterapia)
Rats made obese on a high-fat diet; not a human study.
The extracts and mahanimbine significantly reduced body weight gain and plasma total cholesterol and triglycerides versus untreated high-fat-diet rats, with the effects linked to the carbazole alkaloid content. An animal study only.
A test-tube assay of aqueous curry leaf (and bael) leaf extract for inhibition of alpha-amylase, with GC-MS profiling and molecular docking. (Sangilimuthu et al. 2020, J Complement Integr Med)
Laboratory enzyme assay; no people or animals.
Curry leaf extract inhibited alpha-amylase, the enzyme that converts starch into glucose, in a concentration-dependent way and more strongly than bael extract at low concentrations. A primary laboratory lead that the authors say needs clinical testing.